KNTE - Kinnate Biopharma Inc
IEX Last Trade
2.645
-0.145 -5.482%
Share volume: 211,408
Last Updated: Tue 08 Aug 2023 09:59:36 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.79
-0.15
-5.20%
View ratios
Fiscal Date | |
---|---|
Fiscal Quarter | |
Report Date | |
Assets | |
Total Assets | |
Current Assets | |
Inventories | |
Other Current Assets | |
Short Term Investments | |
Total Receivables | |
Current Cash | |
Total Non-current Assets | |
Property Plant Equipment | |
Other Assets | |
Intangible Assets | |
Goodwill | |
Liabilities and shareholders’ equity | |
Total Liabilities and shareholders’ equity | |
Total liabilities | |
Total current liabilities | |
Accounts Payable | |
Other liabilities | |
Current long term debt | |
Long term debt | |
Other liabilities | |
Minority interest | |
Total Shareholder equity | |
Common stock | |
Retained earnings |